Akebia Therapeutics Inc. (AKBA)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 105,816 | 0.00 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 105,816 | 0.00 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 140,352 | 0.00 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 140,352 | 0.00 | |
| Q4 2020 | |||||
| ≡ | David Abrams - Abrams Capital Management | Sell 100.00% | 5,656,462 | 0.45 | |
| Q3 2020 | |||||
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 15,000,000 | 2.55 | |
| Q2 2020 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 14.42% | 2,527,968 | 0.43 | |
| Q1 2020 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 10.44% | 2,043,485 | 0.23 | |
| Q4 2019 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 20.02% | 4,900,000 | 0.36 | |
| Q4 2018 | |||||
| ≡ | David Abrams - Abrams Capital Management | Add 405.36% | 4,537,176 | 1.03 | |
| ≡ | Seth Klarman - Baupost Group | Buy | 24,471,453 | 1.22 | |
| Q3 2018 | |||||
| ≡ | David Abrams - Abrams Capital Management | Buy | 1,119,286 | 0.26 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.